Cargando…
Treatment of Diabetes in Bullous Pemphigoid Patients: Where Do We Stand?
Autores principales: | Alexandre, Maria Inês, Garrido, Pedro Miguel, Filipe, Paulo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946090/ https://www.ncbi.nlm.nih.gov/pubmed/36892363 http://dx.doi.org/10.5826/dpc.1301a63 |
Ejemplares similares
-
Use of Dupilumab in Bullous Pemphigoid: Where Are We Now?
por: Russo, Roberto, et al.
Publicado: (2022) -
Gene therapy for arthritis – where do we stand?
por: Chernajovsky, Yuti
Publicado: (2005) -
Commentary: Retinopathy of prematurity: Where do we stand?
por: Parchand, Swapnil M, et al.
Publicado: (2021) -
Commentary: COVID-19 and ocular inflammation: Where do we stand and where are we headed?
por: Sheth, Jay U
Publicado: (2021) -
Perioperative care in perforation peritonitis: Where do we stand?
por: Garg, Rakesh
Publicado: (2013)